These results, together with a previous report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 aid the strategy of targeting ACKR3 as a unique solution to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-relevant Conditions. At that point, Microsoft Marketing https://xiaopingp701vqr9.newbigblog.com/profile